#183: Mixed messages on new bleeding data with dabigatran; "high-potency" statins linked to acute kidney injury; dabigatran might cut hospital days vs standard anticoagulants in new AF; US supermarket chain giving away atorvastatin
Mixed messages on new bleeding data with dabigatran; "high-potency" statins linked to acute kidney injury; dabigatran might cut hospital days vs standard anticoagulants in new AF; US supermarket chain giving away atorvastatin (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - March 22, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#27: Heart transplantation: Selecting the ideal candidate
Which patients are the best candidates for heart transplantation? Drs Sudhir Kushwaha and Rocky Daly-respectively the medical and surgical directors of the Heart Transplantation and VAD therapy program at Mayo Clinic-review the steps to selecting patient (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - March 21, 2013 Category: Cardiology Authors: theheart.org Tags: Mayo Clinic Talks Source Type: podcasts
#56: Talking fat with Dr Roger Blumenthal
With an ever-growing percentage of the population either overweight or obese, the topic of staying trim is a matter of international proportions. (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - March 20, 2013 Category: Cardiology Authors: theheart.org Tags: The Bob Harrington Show Source Type: podcasts
#182: ACC 2013: Stopping rivaroxaban and warfarin temporarily in AF patients yields similar risks; PREVAIL yanked from ACC program; Watchman device meets safety end point; Niacin full results in HPS2-THRIVE; Another strike for digoxin in AF
ACC 2013: Stopping rivaroxaban and warfarin temporarily in AF patients yields similar risks; PREVAIL yanked from ACC program; Watchman device meets safety end point; Niacin full results in HPS2-THRIVE; Another strike for digoxin in AF (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - March 13, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#181: What's going to be hot at ACC 2013; rivaroxaban STEMI study hits print as FDA delivers setback; Watchman ups quality of life vs chronic warfarin in nonvalvular AF; FDA again seeks more info on rivaroxaban in ACS
What's going to be hot at ACC 2013; rivaroxaban STEMI study hits print as FDA delivers setback; Watchman ups quality of life vs chronic warfarin in nonvalvular AF; FDA again seeks more info on rivaroxaban in ACS (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - March 7, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#180: "Choosing wisely" now targets over 130 dubious tests, therapies; HPS2-THRIVE: High myopathy risk with niacin/laropiprant; unrestricted Mediterranean diets beat low-fat advice for primary CVD prevention; large proportion of raised LDL cholesterol...
Choosing wisely now targets over 130 dubious tests, therapies; HPS2-THRIVE: High myopathy risk with niacin/laropiprant; unrestricted Mediterranean diets beat low-fat advice for primary CVD prevention; large proportion of raised LDL cholesterol in (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - March 1, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#26: A sign of the times: Social media's impact on SCAD research
Research on spontaneous coronary artery dissection (SCAD) at the Mayo Clinic is a telling example of "patient-initiated" research made possible by social media. Dr Sharonne Hayes discusses with Dr Sharon Mulvagh the genesis of the SCAD project and the... (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - February 25, 2013 Category: Cardiology Authors: theheart.org Tags: Mayo Clinic Talks Source Type: podcasts
